Trial intelligence / Profile preview

Malaria Elimination Strategies in Cambodian Military Forces

NCT02653898Phase 4Unknown

Sponsor
Armed Forces Research Institute of Medical Sciences
Start
Jan 2016
Primary completion
Aug 2016
Modality
Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Allosteric Modulators
Countries
1
01

Overview

A Phase 4 trial of dihydroartemisinin + piperaquine, primaquine, permethrin in malaria, sponsored by Armed Forces Research Institute of Medical Sciences. Status: unknown.

02

Drugs

dihydroartemisinin + piperaquineprimaquinepermethrin
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02653898.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02653898.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call